Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 471
Conférences

le (58m17s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)

... A-I/phospholipids (CSL-111/112)➢ Oral upregulators of endogenous apo A-I production RVX-208: ASSURE, SUSTAIN➢ Phospholipase inhibitors: VISTA-16, SOLID, STABILITY➢ Anti-inflammatory therapy: CANTOS (IL-1β antibody), CIRT (MTX), Anakinra (IL1 RA), IL-6 RA...
Voir la vidéo
Conférences

le (14m26s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Eric STROES)

... A-I/phospholipids (CSL-111/112)➢ Oral upregulators of endogenous apo A-I production RVX-208: ASSURE, SUSTAIN➢ Phospholipase inhibitors: VISTA-16, SOLID, STABILITY➢ Anti-inflammatory therapy: CANTOS (IL-1β antibody), CIRT (MTX), Anakinra (IL1 RA), IL-6 RA...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte